Tokyo, Sept. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058944) titled 'Multicenter Observational Study on Cardiac and Pulmonary Complications in Advanced Lung Cancer Patients Treated with Carbon-Ion Radiotherapy' on Sept. 1.
Study Type:
Observational
Primary Sponsor:
Institute - National Institutes for Quantum Science and Technology
Condition:
Condition - Locally Advanced Lung Cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - The objective is to clarify the effects of heavy-ion beam therapy on the heart, lungs, and esophagus in patients with locally advanced lung cancer by prospectively evaluating adverse events related to these organs in a multicenter study.
Basic objectives2 - Safety
Eligibility:
Age-lower limit - 20
years-old
=
Gender - Male and Female
Key inclusion criteria - Patients who received carbon ion radiotherapy for locally advanced lung cancer between September 1, 2025, and March 31, 2028
Key exclusion criteria - If the research subject or their representative refuses the use of their data for this research
Target Size - 20
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 07 Month 22 Day
Date of IRB - 2025 Year 08 Month 27 Day
Anticipated trial start date - 2025 Year 09 Month 01 Day
Last follow-up date - 2030 Year 05 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067411
Disclaimer: Curated by HT Syndication.
